B
BCTX
Briacell Therapeutics Corp
4.280
-0.260-5.73%After Hours: 4.450 +0.170 +3.97%18:43 04/10 EDT
OPEN/PREV CLOSE4.600/4.540
TODAY RANGE4.210-4.600
VOL139.26K
MARKET CAP31.03M
52 WEEK RANGE3.600-98.20
AVG VOL (3M)494.49K
% TURNOVER1.92%
TURNOVER--
P/E (TTM)-0.1315
% RANGE8.59%
EPS(TTM)-32.5557
P/E(FORWARD)-0.3738
P/B1.004
BVPS4.264
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP30.94M
SHARES OUTSTANDING7.25M
NEXT EARNINGS06/15-06/19
FREE FLOAT7.23M
LOT SIZE1
EX-DATE08/25/2025
News
Press Releases
Financial Reports
Profile
TipRanks·03/31 23:35
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
TipRanks·03/18 11:42
BriaCell to present four posters at the 2026 AACR
Reuters·03/18 11:30
BriaCell to present four posters at the AACR Annual Meeting
Reuters·03/10 21:09
BriaCell Therapeutics Q2 FY2026 net loss widens 15% to USD 7.3 million
Reuters·03/10 11:53
BriaCell to present four posters at the AACR Annual Meeting
TipRanks·03/09 21:16
BriaCell Shareholders Approve Auditors and Reelect Board
TipRanks·03/05 21:53
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting
TipRanks·02/20 21:47
BriaCell Restructures Soluble CD80 Program via BriaPro Deal
Reuters·02/20 21:01
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Same Industry
Name/Symbol
Change%
Price